MV Capital Management’s Edwards Lifesciences EW Stock Holding History

MV Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.2K	Buy	315 +7	+2%	+$577	﹤0.01%	412
2025 Q4	$26.3K	Buy	308 +2	+0.7%	+$164	﹤0.01%	404
2025 Q3	$23.8K	Buy	306 +1	+0.3%	+$78	﹤0.01%	418
2025 Q2	$23.9K	Buy	305 +51	+20%	+$3.8K	﹤0.01%	417
2025 Q1	$18.4K	Sell	254 -20	-7%	-$1.43K	﹤0.01%	445
2024 Q4	$20.3K	Buy	274 +4	+1%	+$280	﹤0.01%	426
2024 Q3	$17.8K	Sell	270 -98	-27%	-$7.12K	﹤0.01%	443
2024 Q2	$34K	Buy	368 +33	+10%	+$2.92K	﹤0.01%	337
2024 Q1	$32K	Sell	335 -21	-6%	-$1.76K	﹤0.01%	354
2023 Q4	$27.1K	Buy	356 +53	+17%	+$3.69K	﹤0.01%	372
2023 Q3	$21K	Sell	303 -321	-51%	-$25.8K	﹤0.01%	384
2023 Q2	$58.9K	Buy	624 +26	+4%	+$2.26K	0.01%	275
2023 Q1	$49.5K	Buy	598 +270	+82%	+$21.2K	0.01%	284
2022 Q4	$24.5K	Sell	328 -1	-0.3%	-$77	﹤0.01%	310
2022 Q3	$27K	Buy	329 +140	+74%	+$13.5K	﹤0.01%	290
2022 Q2	$18K	Sell	189 -39	-17%	-$4.04K	﹤0.01%	334
2022 Q1	$27K	Buy	228 +38	+20%	+$4.26K	﹤0.01%	291
2021 Q4	$25K	Buy	190 +44	+30%	+$5.13K	﹤0.01%	286
2021 Q3	$17K	Buy	146 +54	+59%	+$6.16K	﹤0.01%	337
2021 Q2	$10K	Buy	92 +77	+513%	+$7.26K	﹤0.01%	363
2021 Q1	$1K	Buy	+15	New	+$1.27K	﹤0.01%	359
2015 Q3	–	Sell	-492	Closed	-$12K	–	311
2015 Q2	$12K	Hold	492	–	–	﹤0.01%	290
2015 Q1	$12K	Hold	492	–	–	0.01%	273
2014 Q4	$10K	Buy	+492	New	+$9.88K	﹤0.01%	289

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MV Capital Management's EW Position: Q1 2026 in Review

MV Capital Management increased its Edwards Lifesciences (EW) stake by 2.3% in Q1 2026, buying an estimated $577 and bringing the position to 315 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

MV Capital Management first reported a position in EW in Q4 2014 and has held it in 24 quarters since. The position peaked at $58.9K in Q2 2023. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

MV Capital Management held 315 shares of Edwards Lifesciences worth $25.2K as of Q1 2026.
MV Capital Management bought 7 Edwards Lifesciences shares in Q1 2026, an estimated $577.
Edwards Lifesciences made up ﹤0.01% of MV Capital Management's portfolio in Q1 2026, its #412 holding.
MV Capital Management first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 24 quarters since.
MV Capital Management's Edwards Lifesciences position peaked at $58.9K in Q2 2023.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.